Nahla M. Elsherbiny

439 total citations
21 papers, 323 citations indexed

About

Nahla M. Elsherbiny is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Nahla M. Elsherbiny has authored 21 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Nahla M. Elsherbiny's work include Antibiotic Resistance in Bacteria (4 papers), Diabetes and associated disorders (3 papers) and Gut microbiota and health (3 papers). Nahla M. Elsherbiny is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Diabetes and associated disorders (3 papers) and Gut microbiota and health (3 papers). Nahla M. Elsherbiny collaborates with scholars based in Egypt, United States and Saudi Arabia. Nahla M. Elsherbiny's co-authors include Elham Ahmed Hassan, Enas Daef, Sahar M. Hassany, ‏Helal F. Hetta, Mona Soliman, A. M. Moharram, Mamdoh Eskandar, Amal Rayan, Asmaa M. Zahran and Mohamed A. El‐Mokhtar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Microbiology and International Journal of Infectious Diseases.

In The Last Decade

Nahla M. Elsherbiny

20 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nahla M. Elsherbiny Egypt 10 124 92 79 72 38 21 323
Giorgio Settimo Barreca Italy 15 238 1.9× 132 1.4× 182 2.3× 93 1.3× 42 1.1× 58 510
Abiye Tigabu Ethiopia 11 112 0.9× 79 0.9× 17 0.2× 79 1.1× 28 0.7× 23 387
Ahmad Adebayo Irekeola Malaysia 14 113 0.9× 133 1.4× 39 0.5× 90 1.3× 24 0.6× 39 506
Abeer Ghazal Egypt 10 94 0.8× 71 0.8× 47 0.6× 86 1.2× 36 0.9× 38 301
Angelo Giuseppe Lamberti Italy 10 145 1.2× 80 0.9× 98 1.2× 55 0.8× 19 0.5× 35 326
B Mariani Italy 12 170 1.4× 178 1.9× 82 1.0× 105 1.5× 69 1.8× 43 629
Paul Saleeb United States 8 282 2.3× 129 1.4× 55 0.7× 57 0.8× 83 2.2× 17 415
Julien Lemaire Belgium 14 91 0.7× 18 0.2× 72 0.9× 133 1.8× 142 3.7× 20 561
Wei-Jen Lin Taiwan 12 180 1.5× 209 2.3× 42 0.5× 104 1.4× 98 2.6× 25 485
Jamila H. Champsi United States 8 314 2.5× 140 1.5× 73 0.9× 37 0.5× 39 1.0× 14 460

Countries citing papers authored by Nahla M. Elsherbiny

Since Specialization
Citations

This map shows the geographic impact of Nahla M. Elsherbiny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahla M. Elsherbiny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahla M. Elsherbiny more than expected).

Fields of papers citing papers by Nahla M. Elsherbiny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahla M. Elsherbiny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahla M. Elsherbiny. The network helps show where Nahla M. Elsherbiny may publish in the future.

Co-authorship network of co-authors of Nahla M. Elsherbiny

This figure shows the co-authorship network connecting the top 25 collaborators of Nahla M. Elsherbiny. A scholar is included among the top collaborators of Nahla M. Elsherbiny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahla M. Elsherbiny. Nahla M. Elsherbiny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elsherbiny, Nahla M., et al.. (2025). Direct-acting antiviral treatment significantly shaped the gut microbiota in chronic hepatitis C patients: a pilot study. Frontiers in Microbiology. 16. 1664447–1664447. 2 indexed citations
2.
3.
Elsherbiny, Nahla M., et al.. (2022). Impact of Geographical Location on the Gut Microbiota Profile in Egyptian Children with Type 1 Diabetes Mellitus: A Pilot Study. International Journal of General Medicine. Volume 15. 6173–6187. 8 indexed citations
4.
Ahmed, Asmaa M., et al.. (2022). Performance of chromID® CARBA-SMART medium and carbapenemase inhibition method for the detection of carbapenemases among Gram negative bacilli. SHILAP Revista de lepidopterología. 0(0). 0–0. 1 indexed citations
5.
El‐Badawy, Omnia, Nahla M. Elsherbiny, Elham Ahmed Hassan, et al.. (2022). COVID-19 Infection in Patients with Comorbidities: Clinical and Immunological Insight. Clinical and Applied Thrombosis/Hemostasis. 28. 2985289393–2985289393. 8 indexed citations
6.
Elsherbiny, Nahla M., et al.. (2020). Autoimmune Hepatitis: Shifts in Gut Microbiota and Metabolic Pathways among Egyptian Patients. Microorganisms. 8(7). 1011–1011. 41 indexed citations
7.
El‐Mokhtar, Mohamed A., et al.. (2020). Altered Regulatory B Cell Subsets in Children with Type 1 Diabetes Mellitus. Journal of Immunology Research. 2020(1). 8935694–8935694. 16 indexed citations
8.
Hetta, ‏Helal F., et al.. (2020). Evaluation of the Immune Memory Response to Routine Hbv Vaccine in Egyptian Patients With Type 1 Diabetes. Future Virology. 15(4). 215–222. 1 indexed citations
9.
El‐Badawy, Omnia, et al.. (2019). Phenotypic and Genotypic Characterization of Macrolide, Lincosamide and Streptogramin Resistance among Nosocomial Staphylococci Isolated from Intensive Care Units. The Egyptian Journal of Medical Microbiology. 28(1). 23–29. 1 indexed citations
10.
Elsherbiny, Nahla M., et al.. (2019). Bacteriological Monitoring of Inanimate Surfaces and Equipment in Some Referral Hospitals in Assiut City, Egypt. International Journal of Microbiology. 2019. 1–9. 15 indexed citations
11.
Zahran, Asmaa M., et al.. (2018). Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma.. PubMed. 25(2). 45–52. 17 indexed citations
12.
Daef, Enas, et al.. (2018). Bloodstream Infections in Febrile Neutropenic Pediatric Cancer Patients: Microbiological and Sepsis Biomarkers Insight.. PubMed. 25(2). 21–34. 4 indexed citations
13.
Hassan, Elham Ahmed, et al.. (2017). Health care-associated infections in pre-transplant liver intensive care unit: Perspectives and challenges. Journal of Infection and Public Health. 11(3). 398–404. 15 indexed citations
14.
Elsherbiny, Nahla M., et al.. (2017). Multidrug resistant Stenotrophomonas maltophilia: An emerging cause of hospital acquired infections in Assiut University Hospitals, Egypt. International journal of infection control. 13(1). 3 indexed citations
15.
Daef, Enas, et al.. (2016). Effect of Some Efflux Pump Inhibitors on the Resistance of Some Escherichia Coli Strains to Some Antimicrobial Agents. The Egyptian Journal of Medical Microbiology. 25(4). 1–10. 1 indexed citations
16.
Daef, Enas, et al.. (2014). Evaluation of chromogenic media and seminested PCR in the identification of Candida species. Brazilian Journal of Microbiology. 45(1). 255–262. 37 indexed citations
17.
Hassan, Elham Ahmed, et al.. (2014). Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion. International Journal of Infectious Diseases. 23. 69–74. 64 indexed citations
18.
Elsherbiny, Nahla M., et al.. (2012). Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in south western, Saudi Arabia. Journal of Parasitic Diseases. 38(1). 4–10. 32 indexed citations
19.
Daef, Enas & Nahla M. Elsherbiny. (2012). Clinical and Microbiological Profile of Nosocomial Infections in Adult Intensive Care Units at Assiut University Hospitals, Egypt. 13 indexed citations
20.
Soliman, Mona, et al.. (2012). Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C?. Arab Journal of Gastroenterology. 13(3). 111–115. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgio Settimo Barreca Breakdown of academic impact, for papers by Abiye Tigabu Breakdown of academic impact, for papers by Ahmad Adebayo Irekeola Breakdown of academic impact, for papers by Abeer Ghazal Breakdown of academic impact, for papers by Angelo Giuseppe Lamberti Breakdown of academic impact, for papers by B Mariani Breakdown of academic impact, for papers by Paul Saleeb Breakdown of academic impact, for papers by Julien Lemaire Breakdown of academic impact, for papers by Wei-Jen Lin Breakdown of academic impact, for papers by Jamila H. Champsi
Rankless by CCL
2026